Back to top
more

MEDIFAST (MED)

(Delayed Data from NYSE)

$18.60 USD

18.60
318,956

-0.23 (-1.22%)

Updated Aug 29, 2024 04:00 PM ET

After-Market: $18.58 -0.02 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 251)

Industry: Food - Miscellaneous

Better trading starts here.

Zacks News

Bet on These 5 Top Liquid Stocks for Stellar Returns

Five top-ranked liquid stocks that are poised to offer marvelous returns.

    Can Campbell's Plans Post Strategic Review Revive the Stock?

    Campbell (CPB) unveils various actions as part of its prudent portfolio review and Board-led strategy, aiming at improving performance that has been drab otherwise.

      5 Reasons Why Helen of Troy Stock Must be in Your Portfolio

      Helen of Troy (HELE) is likely to keep its stellar show on, evident from its raised earnings outlook for fiscal 2019.

        Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

        Is (MED) Outperforming Other Consumer Staples Stocks This Year?

          The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast

          The Zacks Analyst Blog Highlights: Turtle Beach, BioLife Solutions, IntriCon and Medifast

            Church & Dwight's International Unit Strong, Margins Soft

            Church & Dwight's (CHD) consumer international business has been consistently contributing to organic sales growth. However, gross margin has been declining for a while now.

              Boston Beer (SAM) Surges Despite Beer Woes: Will it Persist?

              Boston Beer (SAM) rallies despite industry headwinds, including a soft beer category, a shift to healthier drinks and higher costs. The company's non-beer portfolio shows potential for further growth.

                Nitish Marwah headshot

                Trump's Approval Rating Buoy Wall Street: 4 Top Gainers

                Trump's pro-growth agenda has worked wonders for the economy as a whole.

                  Dean Foods Dips to a 52-Week Low, Input Costs a Key Concern

                  Dean Foods (DF) is fighting obstacles related to input cost inflation, tepid volumes and higher retailer investments in the private label space, weighing on its performance.

                    Campbell (CPB) Sees Soft Q4 Earnings, Unveils Strategic Plans

                    Campbell's (CPB) earnings fall due to higher tax rate, lower adjusted EBIT on base business and more. The company unveils various actions to improve business as part of strategic portfolio review.

                      Hain Celestial (HAIN) Q4 Earnings Decline Y/Y, Stock Down

                      Hain Celestial (HAIN) witnesses the third straight quarter of sales miss in Q4. Also, high promotional and trade investments along with freight costs hurt gross margin.

                        Tyson Foods Down 10% in 3 Months, Market Volatility a Worry

                        Tyson Foods' (TSN) Chicken and Pork segment witness unstable market conditions stemming from increased tariffs.

                          Madeleine Johnson headshot

                          Anatomy of Success: Medifast Inc. (MED)

                          This Zacks Rank #1 stock skyrocketed over +130% in just six months.

                            Sanderson Farms (SAFM) Q3 Earnings & Sales Fall Year on Year

                            Sanderson Farms' (SAFM) Q3 results are negatively impacted by lower average selling prices and increased costs of sales.

                              Hormel Foods (HRL) Stock Down 5% Despite Q3 Earnings Beat

                              Hormel Foods' (HRL) top and bottom lines improve year over year in Q3. However, sales lag estimate and management cuts sales outlook.

                                Hershey Up More Than 10% in 3 Months: More Room for Growth?

                                Hershey (HSY) is gaining from its buyout of Amplify, focus on productivity improvements and brand strength. However, escalated costs remain a threat to margins.

                                  Clorox (CLX) Surges 24% in 3 Months: More Room to Run?

                                  Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.

                                    Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting

                                    Zacks.com highlights: Medifast, Endo International, HCA Healthcare, Five9 and FTI Consulting

                                      Can Dean Foods' Cost-Cutting Plans Provide Respite to Stock?

                                      Dean Foods (DF) has been taking steps to reduce unnecessary costs and improve efficiency. These initiatives should help offset some negative impacts from volume declines and higher input costs.

                                        Archer Daniels (ADM) Up 26% YTD: Will the Momentum Continue?

                                        Archer Daniels (ADM) looks promising backed by cost-savings efforts and management of its business portfolio. The company has an impressive earnings surprise trend as well.

                                          Buy These 5 Low-Beta Stocks to Brave Market Volatility

                                          In this article, we have come up with an investment strategy that clearly shows that less risky securities can also generate handsome returns if some parameters are considered.

                                            Helen of Troy Up Post Q1: Earnings Beat Not the Sole Factor

                                            Helen of Troy (HELE) has been gaining from its consistent online sales and digital marketing efforts. Strength in Leadership Brands and Project Refuel has also been driving performance.

                                              Church & Dwight (CHD) Up 20% in 3 Months: More Room to Run?

                                              The company has outpaced the industry in the past three months, gaining from its focus on buyouts, robust international business and innovations.

                                                Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

                                                Is (MED) Outperforming Other Consumer Staples Stocks This Year?

                                                  Sysco (SYY) Looks Good: Stock Adds 6.2% in Session

                                                  Sysco (SYY) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.